IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,634,967 | -66.2% | 481,305 | -62.7% | 0.00% | 0.0% |
| Q2 2023 | $13,730,079 | +105.5% | 1,290,421 | +103.2% | 0.00% | 0.0% |
| Q1 2023 | $6,681,000 | +27016.6% | 635,108 | -68.1% | 0.00% | -66.7% |
| Q4 2022 | $24,638 | -99.6% | 1,988,627 | +242.2% | 0.00% | +200.0% |
| Q3 2022 | $6,022,000 | -27.2% | 581,168 | -19.0% | 0.00% | 0.0% |
| Q2 2022 | $8,273,000 | -17.1% | 717,404 | -9.5% | 0.00% | 0.0% |
| Q1 2022 | $9,974,000 | -33.0% | 792,800 | -37.9% | 0.00% | -50.0% |
| Q4 2021 | $14,889,000 | -35.5% | 1,276,908 | -27.7% | 0.00% | -33.3% |
| Q3 2021 | $23,068,000 | +94.3% | 1,766,294 | +91.5% | 0.00% | +200.0% |
| Q2 2021 | $11,872,000 | -8.4% | 922,467 | -20.5% | 0.00% | -50.0% |
| Q1 2021 | $12,966,000 | +125.5% | 1,159,775 | +129.8% | 0.00% | +100.0% |
| Q4 2020 | $5,749,000 | +638.9% | 504,681 | +510.8% | 0.00% | – |
| Q3 2020 | $778,000 | -6.5% | 82,629 | +2.4% | 0.00% | – |
| Q2 2020 | $832,000 | -29.8% | 80,654 | -31.3% | 0.00% | – |
| Q1 2020 | $1,185,000 | -32.6% | 117,400 | -11.1% | 0.00% | – |
| Q4 2019 | $1,757,000 | +17.8% | 132,045 | -23.9% | 0.00% | – |
| Q3 2019 | $1,491,000 | +148.5% | 173,574 | +212.1% | 0.00% | – |
| Q2 2019 | $600,000 | -89.3% | 55,610 | -86.6% | 0.00% | -100.0% |
| Q1 2019 | $5,609,000 | +109.6% | 414,513 | +60.5% | 0.00% | 0.0% |
| Q4 2018 | $2,676,000 | +32.5% | 258,308 | +136.0% | 0.00% | – |
| Q3 2018 | $2,020,000 | -81.6% | 109,435 | -81.0% | 0.00% | -100.0% |
| Q2 2018 | $10,988,000 | +627.2% | 574,669 | +486.4% | 0.00% | – |
| Q1 2018 | $1,511,000 | -77.4% | 97,992 | -78.1% | 0.00% | -100.0% |
| Q4 2017 | $6,696,000 | +2053.1% | 446,701 | +2177.9% | 0.00% | – |
| Q3 2017 | $311,000 | -76.9% | 19,610 | -72.5% | 0.00% | – |
| Q2 2017 | $1,346,000 | -72.2% | 71,311 | -74.9% | 0.00% | -100.0% |
| Q1 2017 | $4,850,000 | +3364.3% | 284,369 | +3004.1% | 0.00% | – |
| Q4 2016 | $140,000 | +418.5% | 9,161 | +448.9% | 0.00% | – |
| Q3 2016 | $27,000 | -99.6% | 1,669 | -99.7% | 0.00% | -100.0% |
| Q2 2016 | $7,237,000 | -13.5% | 553,489 | -27.6% | 0.00% | 0.0% |
| Q1 2016 | $8,365,000 | -4.3% | 764,631 | +1.3% | 0.00% | 0.0% |
| Q4 2015 | $8,745,000 | +15.1% | 754,529 | +3.4% | 0.00% | 0.0% |
| Q3 2015 | $7,601,000 | +20.9% | 729,407 | +39.9% | 0.00% | +100.0% |
| Q2 2015 | $6,285,000 | -67.0% | 521,210 | -56.3% | 0.00% | -75.0% |
| Q1 2015 | $19,071,000 | +1158.8% | 1,191,963 | +1105.2% | 0.00% | – |
| Q4 2014 | $1,515,000 | +227.2% | 98,900 | +176.5% | 0.00% | – |
| Q3 2014 | $463,000 | -85.9% | 35,775 | -86.5% | 0.00% | -100.0% |
| Q1 2014 | $3,273,000 | +116.6% | 265,641 | +104.2% | 0.00% | – |
| Q4 2013 | $1,511,000 | -12.9% | 130,078 | -11.2% | 0.00% | -100.0% |
| Q3 2013 | $1,734,000 | +81.0% | 146,474 | +51.7% | 0.00% | – |
| Q2 2013 | $958,000 | – | 96,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |